The Effect of Pulmonary Rehabilitation on Bronchoscopic Volume Reduction Process Success

Emphysema Clinical Trial

Official title:

The Effect of Pulmonary Rehabilitation on Bronchoscopic Volume Reduction Process Success

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04347044
• Other study ID #: BLVR_PR
• Status: Completed
• Phase: N/A
• Start date: January 1, 2013
• Est. completion date: August 18, 2020

Study information

• Verified date: April 2020
• Source: Istanbul Medipol University Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The data of patients undergoing bronchoscopic volume reduction procedure will be analyzed retrospectively. Patients will be divided into two groups as patients with and without Pulmonary Rehabilitation before the procedure, and changes in functional levels of patients will be compared.

Description:

The data of patients who underwent bronchoscopic volume reduction between January 2013 and March 2019 will be examined.

Patients will be divided into two groups as pulmonary rehabilitation applied (PR group) and not applied (Control group) before the procedure.

Changes in the parameters of initial and rehabilitation follow-up will be examined.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 80
• Est. completion date: August 18, 2020
• Est. primary completion date: August 18, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 75 Years

Eligibility

Inclusion Criteria:

• Between the ages of 18-75

• Patients with a diagnosis of emphysema and bronchoscopic procedures

Exclusion Criteria:

• Patients who develop complications related to the procedure after bronchoscopic procedure.

Related Conditions & MeSH terms

• Bronchoscopic Lung Volume Reduction
• Emphysema
• Pulmonary Rehabilitation

Intervention

Other:
• Pulmonary Rehabilitation
Exercise training+ Optimal medication and clinical follow-up
• Standart care
Optimal medication and clinical follow-up

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Istanbul Medipol University Hospital

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Six minute walking test	The test was conducted in a 30-meter corridor in line with American Thoracic Society (ATS) guidelines. Patients were asked to walk as far as they can. Prior to and following the test, oxygen saturation, heart rate and Borg fatigue rating were measured, and the walking distance were recorded	20 minutes
Primary	Pulmonary Function Tests	PFTs were performed by using the Sensormedics model 2400 (Yorba Linda, CA, USA) spirometry device, and according to the American Thoracic Society (ATS) guidelines	15 minutes
Secondary	Carbonmonoxide diffusion test	It will performed in the pulmonary function test laboratory using Cosmed Quark PFT (USA) with single-breath technique	15 minutes